Company

Immunexpress Inc.

Biotechnology Research 425 Pontius Ave N 15 employees

Employees: 15
Contacts: 4
Emails: 4
Phones: 2

immunexpress.com LinkedIn Crunchbase

Immunexpress Inc. Overview

Headquarters: 425 Pontius Ave N
Website: immunexpress.com
Industry: Biotechnology Research
Employees: 15
Founded: 2006
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Medical devices Molecular diagnostics Sepsis

About Immunexpress Inc.

Immunexpress is a privately owned company creating revolutionary molecular diagnostics for sepsis. The company has offices in Seattle, USA and Brisbane, Australia. Immunexpress's product pipeline aims to address the overwhelming unmet clinical needs of sepsis patients, as well as clinicians, payers and healthcare systems. Unlike the traditional approach to sepsis diagnosis, SeptiCyte® quantifies the specific molecular biomarkers from a patient's immune system ('host response'). Biomarkers capture signals from a patient's immune system in response to infection. These biomarkers may hold the key to early detection of sepsis, as well as guiding the use and timing of drugs and other therapies.

Immunexpress Inc. Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 2; 50.0% coverage

Immunexpress Inc. Org Chart

Sample employees and titles

Name	Title	Location	Contact
Carol Whisenant	Office Manager and Executive Assistant	Seattle, Washington, United States	Email Phone
Jane (Markley) Papadaki	VP of Market Development & Commercial	Austin, Texas, United States	Email
Thomas Yager	Sr. Director, Research & Development	Toronto, Ontario, Canada	Email
Greg Uhl	Director Finance at Immunexpress Inc.	Milton, Washington, United States	Email Phone